Advertisement

Urolithiasis pp 241-244 | Cite as

Long-Term Treatment with Bendroflumethiazide for Prevention of Renal Stones. Clinical Experiences

  • S. Ljunghall
  • U. Backman
  • B. G. Danielson
  • B. Fellström
  • G. Johansson
  • B. Wikström

Abstract

It has long been recognized that thiazides reduce the urinary calcium output and studies, where larger numbers of patients have been studied1,2 have reported that during long-term follow-up most patients will be free of recurrences.

Keywords

Stone Formation Urinary Calcium Renal Stone Stone Disease Stone Patient 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    E. R. Yendt and M. Cohanim, Kid. Int. 13:387 (1978).CrossRefGoogle Scholar
  2. 2.
    F. L. Coe, Ann. Int. Med. 87:404 (1977).PubMedGoogle Scholar
  3. 3.
    S. Ljunghall, U. Backman, B. G. Danielson, B. Fellstrom,G. Johansson, and B. Wikstrom, Scand. J. Uro1. Nephro1.Supp1. 54 (in press).Google Scholar
  4. 4.
    W. G. Robertson, M. Peacock, P. J. Heyburn, D. H. Marshall, and B. E. C. Nordin, NEJM 294:249 (1976).CrossRefGoogle Scholar
  5. 5.
    S. Ljungha11, U. Backman, B. G. Danielson, B. Fe11strom,G. Johansson, and B. Wikstrom, Scand. J. Uro1. Nephro1.Supp1. 54 (in press).Google Scholar
  6. 6.
    J. Zerwekh, and C. Y. C. Pak, Metabolism 29:13 (1980).PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1981

Authors and Affiliations

  • S. Ljunghall
    • 1
  • U. Backman
    • 1
  • B. G. Danielson
    • 1
  • B. Fellström
    • 1
  • G. Johansson
    • 1
  • B. Wikström
    • 1
  1. 1.Department of Internal MedicineUniversity HospitalUppsalaSweden

Personalised recommendations